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Background: Our goal was to determine risk factors and timing of onset for systemic hypertension (HTN) in preterm children. 
methods: We evaluated children with systemic HTN and history of prematurity (gestational age <37 weeks) seen consecutively in a pediatric 
hypertension clinic over a six year period. We collected their demographic and clinical history by retrospective chart review. Patients with lack of 
documented medical history and those lost to follow-up were excluded.
results: We identified 38 preterm hypertensive children (see Table). Of these, 22 were diagnosed in the neonatal period (neonatal HTN) and 16 
were diagnosed at older age (clinic HTN). There was no difference in gender, birth weight or family history between the two groups. When compared 
to clinic HTN, those with neonatal diagnosis had a significantly lower gestational age, longer stay in the NICU and had higher incidence of neonatal 
risk factors for hypertension (i.e. BPD, umbilical catheterization, intubation) as well as a higher incidence of resolution of HTN. In contrast, those with 
clinic HTN had more traditional risk factors (i.e. ethnicity, obesity).
conclusions: There was a bimodal onset of systemic HTN in preterm children: Early onset in the NICU with significantly higher neonatal risk factors 
and higher likelihood of resolution, or late onset in the ambulatory setting with significantly higher incidence of traditional risk factors. 
Table.  
Total Diagnosed in NICU Diagnosed in Clinic P value
n 38 22 16
Age at Enrollment, years 7.11 (5.95) 3.29 (2.03) 12 (5.53) < 0.01
Age at Diagnosis, years 4.40 (5.95) 0.27 (0.17) 10 (5.25) < 0.01
Weight at Diagnosis, kg 22.7 (31.0) 3.11 (1.30) 50.6 (31.7) < 0.01
Male Gender, n (%) 26 (68) 15 (68) 11 (69) 0.97
Ethnicity, n (%)
African American
Asian
Caucasian
Hispanic
Other
13 (34)
1 (3)
13 (34)
7 (18)
4 (11)
3 (14)
0 (0)
10 (45)
6 (27)
3 (14)
10 (63)
1 (6)
3 (19)
1 (6)
1 (6)
<0.01
0.23
0.09
0.10
0.46
Gestational HTN, n (%) 6 (16) 4 (18) 2 (13) 0.64
Family History of HTN, n (%) 24 (63) 13 (59) 11 (69) 0.54
Delivery Type, n (%)
Vaginal
Cesarean
Unknown
6 (16)
20 (53) 12 (31)
6 (27)
15 (68)
1 (5)
0 (0)
5 (31)
11 (69)
0.17
Gestational Age at Birth, weeks 29 (3.91) 28 (3.56) 31 (3.65) < 0.01
Birth Weight, grams 1191 (559) 1163 (510) 1257 (688) 0.682
Average Duration in NICU, months 3 (2.55) 4 (2.42) 1.5 (1.74) < 0.01
Intubation, n (%) 28 (74) 21 (95) 7 (44) < 0.01
O2 Therapy, n (%) 29 (76) 21 (95) 8 (50) < 0.01
Bronchopulmonary Dysplasia, n (%) 19 (50) 15 (68) 4 (25) < 0.01
Patent Ductus Arteriosus, n (%) 14 (37) 13 (59) 1 (6) < 0.01
Umbilical Catheterization, n (%) 16 (42) 12 (54) 4 (25) 0.07
Renal Disease, n (%) 3 (8) 3 (14) 0 (0) 0.12
Hypertension Type, n (%)
Systolic
Diastolic
Combined
19 (50)
0 (0)
18 (47)
9 (41)
0 (0)
13 (59)
10 (63)
0 (0)
5 (31)
0.19
NA
0.09
Left Ventricular Hypertrophy, n (%) 3 (8) 1 (5) 2 (13) 0.37
Abnormal Renal US, n (%) 7 (18) 6 (27) 1 (6) 0.10
HTN Medication in NICU, n (%) 19 (50) 19 (86) 0 (0) < 0.01
HTN Medication in Clinic, n (%) 33 (87) 22 (100) 11 (69) < 0.01
Duration of HTN Medication in Clinic, months 16 (16.4) 9.5 (7.56) 26 (23.4) < 0.01
Resolution of HTN, n (%) 28 (74) 21 (95) 7 (44) < 0.01
All continuous variables given in mean (±SD).
